肯尼亚的FY.4 Omicron变种的出现和传播动态
Sebastian Musundi1, Mike Mwanga1, Arnold Lambisia1
1Department of Epidemiology & Demography, KEMRI-Wellcome Trust Research Programme, P.O. Box 230-80108, Kilifi, Kenya.
Virus evolution
|June 27, 2025
概括
第4财年严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 变种于2022年底在肯尼亚出现,在2023年初成为主导. 这种变种在全球传播,凸显了加强基因组监测的必要性.
科学领域:
- 病毒学 病毒学
- 基因组学就是基因组学.
- 流行病学 流行病学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 持续演变,导致新变种的出现.
- 由突变Y451H和P42L识别的FY.4变种于2023年3月在肯尼亚被检测到.
研究的目的:
- 调查FY.4SARS-CoV-2变种的起源和全球传播.
- 了解FY.4.4的进化动态和传播模式.
主要方法:
- 人类遗传学分析
- 植物动力学建模.
- 基因组监测数据分析的分析.
- 流行病学数据整合.
主要成果:
- 这种FY.4变种可能起源于肯尼亚,大约在2022年12月左右.
- 从2023年4月到7月,FY.4成为肯尼亚的SARS-CoV-2主要变种.
- 该变种在国际上传播,在北美,欧洲和亚太地区爆发疫情.
结论:
- 持续的基因组监测对于跟踪SARS-CoV-2变种演变和传播至关重要.
- 样本不足的地区在了解全球变异动态方面发挥着至关重要的作用.
- FY.4变种的出现和传播强调了持续监测病毒演变的必要性.
相关概念视频
Steps in Outbreak Investigation
213
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
213
Infection
8.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
8.8K
Transmission-based Precautions I: Contact, Enteric, and Droplets
4.1K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.1K
Transmission-based Precautions II: Airborne and Protective Environment
1.5K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.5K
Viral Mutations
33.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
33.1K
Causality in Epidemiology
899
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
899


